Nuvation Bio (NUVB) Inventory (2025 - 2026)
Nuvation Bio (NUVB) posted quarterly Inventory of $15.8 million for Q1 2026, up 113071.43% year-over-year from N/an in Q1 2025, and up 38.85% quarter-over-quarter from $11.4 million in Q4 2025.
Nuvation Bio (NUVB) Inventory (2025 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Inventory for 2 consecutive years, with $15.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 113071.43% year-over-year to $15.8 million; the TTM figure through Mar 2026 stood at $15.8 million (up 113071.43% YoY), while the FY2025 annual figure was $11.4 million, changed N/A from the prior year.
- Inventory rose to $15.8 million in Q1 2026 per NUVB's latest filing, from $11.4 million in the prior quarter.
- Across five years, Inventory topped out at $15.8 million in Q1 2026 and bottomed at $14000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 19.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.90 Mn |
| Mar 31, 2026 | 15.84 Mn |
| Dec 31, 2025 | 11.41 Mn |
| Sep 30, 2025 | 5.71 Mn |
| Jun 30, 2025 | 552,000.00 |
| Mar 31, 2025 | 14,000.00 |